- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 342371, 6 pages
UGT1A1 Gene Mutation due to Crigler-Najjar Syndrome in Iranian Patients: Identification of a Novel Mutation
1Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Genetic Department, Faculty of Science, Shahid Chamran Univerity, Ahvaz, Iran
3Pediatric Department, Ahvaz Jundishapur University of Medical Sciences, Golestan Hospital, Golestan, Ahvaz, Iran
4Noor Genetic Diagnostic Laboratory, Ahvaz, Iran
5Toxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Received 9 April 2013; Revised 27 June 2013; Accepted 27 June 2013
Academic Editor: Thomas Liehr
Copyright © 2013 Javad Mohammadi Asl et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. Lodoso Torrecilla, E. Palomo Atance, C. Camarena Grande et al., “Crigler-Najjar syndrome: diagnosis and treatment,” Anales de Pediatria, vol. 65, no. 1, pp. 73–78, 2006.
- C. Huang, N. Tan, S. Yang, Y. Sung, and M. Huang, “Crigler-Najjar syndrome type 2,” Journal of the Formosan Medical Association, vol. 105, no. 11, pp. 950–953, 2006.
- M. Torres and M. Bruguera, “Crigler-Najjar syndrome,” Gastroenterologia y Hepatologia, vol. 28, no. 10, Article ID 103.412, pp. 637–640, 2005.
- S. Itoh, “Crigler-Najjar syndrome,” Ryoikibetsu Shokogun Shirizu, no. 33, pp. 519–521, 2001.
- M. Jesic and S. Maglajlic, “The Crigler-Najjar syndrome, type I. Therapeutic dilemmas,” Srpski Arhiv za Celokupno Lekarstvo, vol. 128, no. 11-12, pp. 389–392, 2000.
- A. Iolascon, A. Melon, B. Coppola, and M. C. Rosatelli, “Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene,” Journal of Medical Genetics, vol. 37, no. 9, pp. 712–713, 2000.
- M. I. Shevell, B. Bernard, and J. W. Adelson, “Crigler-Najjar syndrome type I: treatment by home phototherapy followed by orthotopic hepatic transplantation,” Journal of Pediatrics, vol. 110, no. 3, pp. 429–431, 1987.
- M. I. Shevell, A. Majnemer, and D. Schiff, “Neurologic perspectives of Crigler-Najjar syndrome type I,” Journal of Child Neurology, vol. 13, no. 6, pp. 265–269, 1998.
- H. Ihara, H. Nakamura, Y. Aoki, T. Aoki, and M. Yoshida, “In vitro effects of light on serum bilirubin subfractions measured by high-performance liquid chromatography: comparison with four routine methods,” Clinical Chemistry, vol. 38, no. 10, pp. 2124–2129, 1992.
- P. J. Bosma, J. R. Chowdhury, T.-J. Huang et al., “Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I,” The FASEB Journal, vol. 6, no. 10, pp. 2859–2863, 1992.
- P. J. Bosma, N. R. Chowdhury, B. G. Goldhoorn et al., “Sequence of exons of the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I,” Hepatology, vol. 15, no. 5, pp. 941–947, 1992.
- P. J. Bosma, B. Goldhoorn, R. P. J. O. Elferink, M. Sinaasappel, B. A. Oostra, and P. L. M. Jansen, “A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II,” Gastroenterology, vol. 105, no. 1, pp. 216–220, 1993.
- E. Plöchl and W. Hohenwallner, “Treatment of Crigler-Najjar's congenital familial non-hemolytic jaundice with kernicterus,” Wiener Medizinische Wochenschrift, vol. 128, no. 3, pp. 70–73, 1978.
- C. P. Strassburg, “Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome),” Best Practice and Research, vol. 24, no. 5, pp. 555–571, 2010.
- S. Pett and A. P. Mowat, “Crigler-Najjar syndrome types I and II. Clinical experience—King's College Hospital 1972–1978. Phenobarbitone, phototherapy and liver transplantation,” Molecular Aspects of Medicine, vol. 9, no. 5, pp. 473–482, 1987.
- A. Kadakol, S. S. Ghosh, B. S. Sappal, G. Sharma, J. R. Chowdhury, and N. R. Chowdhury, “Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype,” Human Mutation, vol. 16, no. 4, pp. 297–306, 2000.
- F. Rossi, M. Francese, R. M. Iodice et al., “Inherited disorders of bilirubin metabolism,” Minerva Pediatrica, vol. 57, no. 2, pp. 53–63, 2005.